Evidence map›Paper›PMID 28182539›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2017

Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season.

Richard Pebody, Bersabeh Sile, Fiona Warburton, Mary Sinnathamby, Camille Tsang, Hongxin Zhao, Joanna Ellis, Nick Andrews

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Live Attenuated Cold-Adapted Influenza Vaccines.Cold Spring Harbor perspectives in medicine · 2021
    Review
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. [The universal influenza vaccination in children with Vaxigrip TetraJournal of preventive medicine and hygiene · 2018
    Article
  14. Immune responses after live attenuated influenza vaccination.Human vaccines & immunotherapeutics · 2018
    Review
  15. 2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Observational
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Richard PebodyNational Infection Service, Public Health England, London, United Kingdom.
Bersabeh SileNational Infection Service, Public Health England, London, United Kingdom.
Fiona WarburtonNational Infection Service, Public Health England, London, United Kingdom.
Mary SinnathambyNational Infection Service, Public Health England, London, United Kingdom.
Camille TsangNational Infection Service, Public Health England, London, United Kingdom.
Hongxin ZhaoNational Infection Service, Public Health England, London, United Kingdom.
Joanna EllisNational Infection Service, Public Health England, London, United Kingdom.
Nick AndrewsNational Infection Service, Public Health England, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The United Kingdom is introducing a universal annual influenza vaccination programme for children. Live attenuated influenza vaccine (LAIV) effectiveness (VE) against laboratory-confirmed influenza hospitalisation in 2 to 6 year-olds in England was measured in 2015/16 using the screening method. VE adjusted for age, geography and month was 54.5% (95% confidence interval (CI): 31.5% to 68.4%) for all influenza types combined; 48.3% (95% CI: 16.9% to 67.8%) for A(H1N1)pdm09 and 70.6% (95% CI: 33.2% to 87.1%) for B. The findings support on-going programme roll-out.

Indexed as

AdolescentCase-Control StudiesChildChild, PreschoolDisease OutbreaksEnglandFemaleHospitalizationHumansImmunization ProgramsInfluenza A Virus, H1N1 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesLaboratoriesMaleInfluenza VaccinesVaccines, AttenuatedhospitalisationinfluenzaLAIVvaccine effectiveness

Identifiers

PMID28182539
PMCPMC5388092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.